Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.

Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...

Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Inovio Pharmaceuticals Inc INO shares are trading lower by 40% to $2.23 during Friday’s ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

Latest on INO: Exclusive BAC Article: Inovio Pharmaceuticals; BLA Filing INO-3107 For RRP 2nd Half Of 2024, GBM Program Update INO-5401 1st Half Of 2024 And Catalysts ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public ...

View Inovio option chain data and compare options for INO stock. Gain insights into the options market sentiment and the potential trading activity surrounding Inovio stock. View the call options (the ...